相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication
Liu Shi et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Amsterdam Dementia Cohort: Performing Research to Optimize Care
Wiesje M. van der Flier et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Use of Flutemetamol F18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
David A. Wolk et al.
JAMA NEUROLOGY (2018)
Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly
Rosalinde E. R. Slot et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease
Nour K. Majbour et al.
SCIENTIFIC REPORTS (2017)
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod et al.
ALZHEIMERS & DEMENTIA (2017)
Low levels of ficolin-3 are associated with diabetic peripheral neuropathy
Xiaoyan Zhang et al.
ACTA DIABETOLOGICA (2016)
Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly
Sarah Westwood et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis
Willemijn J. Jansen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
Daniel Alcolea et al.
NEUROLOGY (2015)
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
Sebastian Palmqvist et al.
NEUROLOGY (2015)
DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes
Janet Pinero et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2015)
Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
Jon B. Toledo et al.
JAMA NEUROLOGY (2015)
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology
Alison L. Baird et al.
FRONTIERS IN NEUROLOGY (2015)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
Blood Protein Markers of Neocortical Amyloid-beta Burden: A Candidate Study Using SOMAscan Technology
Nicola Voyle et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Plasma proteins predict conversion to dementia from prodromal disease
Abdul Hye et al.
ALZHEIMERS & DEMENTIA (2014)
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
Martina Sattlecker et al.
ALZHEIMERS & DEMENTIA (2014)
Bone Loss and Osteoporosis are Associated with Conversion from Mild Cognitive Impairment to Alzheimer's Disease
Rui Zhou et al.
CURRENT ALZHEIMER RESEARCH (2014)
Apolipoprotein C-III is an Amyloid-beta-Binding Protein and an Early Marker for Alzheimer's Disease
Yao-Hsiang Shih et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
Wiesje M. van der Flier et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease
Daniela Galimberti et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Protein-Based Biomarkers in Cerebrospinal Fluid and Blood for Alzheimer's Disease
Yongyao Fu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
Danielle Welter et al.
NUCLEIC ACIDS RESEARCH (2014)
Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β1-42 and τ Proteins as Alzheimer Disease Biomarkers
Ju-Hee Kang et al.
CLINICAL CHEMISTRY (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Human L-Ficolin (Ficolin-2) and Its Clinical Significance
David C. Kilpatrick et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Konrad Talbot et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
William T. Hu et al.
NEUROLOGY (2012)
Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals
Fei Song et al.
PLOS ONE (2012)
Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden
Steven John Kiddle et al.
PLOS ONE (2012)
Low serum levels of the innate immune component ficolin-3 is associated with insulin resistance and predicts the development of type 2 diabetes
Haibing Chen et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Serum Levels of Pregnancy Zone Protein are Elevated in Presymptomatic Alzheimer's Disease
Linda Ijsselstijn et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
Madhav Thambisetty et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Blood-based biomarkers of Alzheimer's disease: challenging but feasible
Madhav Thambisetty et al.
BIOMARKERS IN MEDICINE (2010)
Amyloid-β(1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
Cees Mulder et al.
CLINICAL CHEMISTRY (2010)
Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease
Kelly R. Bales
NEUROPHARMACOLOGY (2010)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Lesley Jones et al.
PLOS ONE (2010)
Human apolipoprotein A-I binds amyloid-β and prevents Aβ-induced neurotoxicity
Andrea C. Paula-Lima et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Localized-Statistical Quantification of Human Serum Proteome Associated with Type 2 Diabetes
Rong-Xia Li et al.
PLOS ONE (2008)
Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease
HC Liu et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Reactome: a knowledgebase of biological pathways
G Joshi-Tope et al.
NUCLEIC ACIDS RESEARCH (2005)
The lectin-complement pathway - its role in innate immunity and evolution
T Fujita et al.
IMMUNOLOGICAL REVIEWS (2004)
Increased risk of type 2 diabetes in Alzheimer disease
J Janson et al.
DIABETES (2004)
Amyloid beta-protein interactions with membranes and cholesterol:: causes or casualties of Alzheimer's disease
WG Wood et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
Aberrant profiles of native and oxidized glypoproteins in Alzheimer plasma
HL Yu et al.
PROTEOMICS (2003)
Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
LM Refolo et al.
NEUROBIOLOGY OF DISEASE (2000)
分享论文
